Sameer Khasbage

586 total citations
13 papers, 96 citations indexed

About

Sameer Khasbage is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Sameer Khasbage has authored 13 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in Sameer Khasbage's work include Vaccine Coverage and Hesitancy (3 papers), Pain Mechanisms and Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Sameer Khasbage is often cited by papers focused on Vaccine Coverage and Hesitancy (3 papers), Pain Mechanisms and Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Sameer Khasbage collaborates with scholars based in India and United Kingdom. Sameer Khasbage's co-authors include Surjit Singh, Tarun Kumar, Siddhartha Dutta, Shoban Babu Varthya, Ravindra Shukla, Praveen Sharma, Jaspreet Kaur Sidhu, Bharti Bhandari, Rimple Jeet Kaur and Shubham Atal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Osteoporosis International and Frontiers in Pharmacology.

In The Last Decade

Sameer Khasbage

10 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sameer Khasbage India 5 36 32 31 16 14 13 96
S. V. Yureneva Russia 6 25 0.7× 21 0.7× 15 0.5× 4 0.3× 9 0.6× 44 119
Marija K. Simic Australia 5 23 0.6× 12 0.4× 23 0.7× 7 0.4× 14 1.0× 6 63
Prashant Tripathi India 5 12 0.3× 4 0.1× 11 0.4× 10 0.6× 5 0.4× 26 64
Loretta Giunta Italy 7 16 0.4× 22 0.7× 34 1.1× 7 0.4× 10 0.7× 8 238
Burak Giray Türkiye 6 13 0.4× 7 0.2× 30 1.0× 9 0.6× 16 1.1× 26 118
Amir Rahnama Iran 7 8 0.2× 3 0.1× 12 0.4× 13 0.8× 18 1.3× 17 100
Ruth Soriano Mexico 3 15 0.4× 36 1.1× 25 0.8× 12 0.8× 3 0.2× 3 61
Carla De Benedittis Italy 5 8 0.2× 3 0.1× 10 0.3× 7 0.4× 27 1.9× 10 113
Audrey Lemaçon Canada 4 7 0.2× 5 0.2× 16 0.5× 10 0.6× 10 0.7× 10 89
Angela Carlone Italy 4 4 0.1× 11 0.3× 18 0.6× 4 0.3× 6 0.4× 7 62

Countries citing papers authored by Sameer Khasbage

Since Specialization
Citations

This map shows the geographic impact of Sameer Khasbage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Khasbage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Khasbage more than expected).

Fields of papers citing papers by Sameer Khasbage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameer Khasbage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Khasbage. The network helps show where Sameer Khasbage may publish in the future.

Co-authorship network of co-authors of Sameer Khasbage

This figure shows the co-authorship network connecting the top 25 collaborators of Sameer Khasbage. A scholar is included among the top collaborators of Sameer Khasbage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameer Khasbage. Sameer Khasbage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ramanuj, Parashar & Sameer Khasbage. (2025). Levofloxacin-induced focal seizure in a patient with multidrug-resistant tuberculosis and chronic kidney disease. BMJ Case Reports. 18(12). e269834–e269834.
5.
Najmi, Ahmad, et al.. (2023). Evaluation of prescribing pattern of drugs and compliance to standard treatment guidelines in patients of chronic hepatitis B: a prospective observational study. International Journal of Basic & Clinical Pharmacology. 12(4). 509–514. 1 indexed citations
6.
Khasbage, Sameer, et al.. (2023). Primary Prophylaxis of COVID-19: A Comprehensive Review of approved vaccines. Research Journal of Pharmacy and Technology. 917–923. 1 indexed citations
7.
Singh, Surjit, Sameer Khasbage, Rimple Jeet Kaur, Jaspreet Kaur Sidhu, & Bharti Bhandari. (2022). Chimeric antigen receptor T cell. Indian Journal of Pharmacology. 54(3). 226–233. 12 indexed citations
8.
Singh, Surjit, et al.. (2021). A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis. Osteoporosis International. 33(1). 1–12. 51 indexed citations
9.
Singh, Surjit, Daisy Khera, Ankita Chugh, et al.. (2021). BCG vaccination impact on mortality and recovery rates in COVID-19: A meta-analysis. Monaldi Archives for Chest Disease. 91(4). 6 indexed citations
10.
Singh, Surjit, et al.. (2020). Duloxetine-induced hypertensive urgency in type 2 diabetes mellitus with diabetic neuropathy. Indian Journal of Pharmacology. 52(3). 213–213. 3 indexed citations
11.
Khera, Daisy, Ankita Chugh, Sameer Khasbage, & Surjit Singh. (2020). BCG vaccination provides protection against COVID 19: A Systematic review and meta-analysis. 1 indexed citations
12.
Kumar, Tarun, et al.. (2020). Dermatological Manifestations of COVID-19: A Review Based on Existing Reports. International Journal of Current Research and Review. 12(13). 65–68. 5 indexed citations
13.
Khasbage, Sameer, Ravindra Shukla, Praveen Sharma, & Surjit Singh. (2020). A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy. Journal of Diabetes. 13(7). 532–541. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026